Blog

Antibiotic resistance develops when bacteria become less sensitive to antibiotics, rendering them less effective or ineffective at killing bacteria and treating infections. We urgently need new therapeutic strategies to combat...

  Innovative UK phage biotechnology company, Fixed Phage, has appointed Dr Neil Clelland as its new Chief Executive Officer (CEO). The company has also announced its new Chief Operations Officer...

Bacteriophages are viruses that specifically target and destroy pathogenic bacteria, making them a promising research topic with significant implications for human health and the environment. Bacteriophage-based solutions can be applied...

Personalised phage therapy is a therapeutic approach that involves using tailored bacteriophages to target and eliminate specific, harmful bacterial infections in a patient. This therapy is currently being explored as...